Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Alzheimer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03055741
What this trial is testing

Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)

Who this might be right for
Mild-moderate Alzheimer's Disease
Daehwa Pharmaceutical Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT00945672
What this trial is testing

A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 36
Testing effectiveness (Phase 2)Study completedNCT03625622
What this trial is testing

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
AriBio Co., Ltd. 210
Testing effectiveness (Phase 2)Study completedNCT00285077
What this trial is testing

Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Sanofi 390
Not applicableStudy completedNCT03611439
What this trial is testing

Effects of an 8 Component Botanical Supplement on Mild and Moderate Alzheimer's Patients

Who this might be right for
Alzheimer DiseaseAlzheimer Dementia
Genescient Corporation 50
Large-scale testing (Phase 3)UnknownNCT03283059
What this trial is testing

Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Shanghai Mental Health Center 600
Not applicableStudy completedNCT06471660
What this trial is testing

Family Caregiver Online Survey (Dementia and Swallowing Difficulties)

Who this might be right for
DementiaDysphagiaDementia Alzheimers+9 more
University of Oregon 219
Testing effectiveness (Phase 2)Study completedNCT00708552
What this trial is testing

Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 576
Not applicableUnknownNCT04260724
What this trial is testing

Study on the Effect of Transcranial Magnetic Stimulation in Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer Disease
Samsung Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT00742417
What this trial is testing

Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid

Who this might be right for
Alzheimer's Disease
Instituto Grifols, S.A. 42
Not applicableStudy completedNCT05591313
What this trial is testing

Acute Exercise on Neurocognitive Function Among Adults With/Without Generic Risk of AD

Who this might be right for
Alzheimer Disease 2 Due to Apoe4 Isoform
National Taiwan Normal University 51
Very early researchStudy completedNCT01024660
What this trial is testing

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

Who this might be right for
Alzheimer's Disease
AstraZeneca 155
Not applicableLooking for participantsNCT07361887
What this trial is testing

Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles.

Who this might be right for
Atherosclerosis Cardiovascular DiseaseObesityMetabolic Syndrome+5 more
University of Seville 8
Early research (Phase 1)Study completedNCT00733642
What this trial is testing

Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 15
Testing effectiveness (Phase 2)UnknownNCT06096090
What this trial is testing

Phase II Clinical Trial of Interleukin-2 in AD

Who this might be right for
Alzheimer Disease
The Methodist Hospital Research Institute 40
Testing effectiveness (Phase 2)Ended earlyNCT05602727
What this trial is testing

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 99
Not applicableStudy completedNCT02205710
What this trial is testing

Adaptive Cognitive Training in Healthy Older Adults

Who this might be right for
Mild Cognitive ImpairmentMild to Moderate DementiaAlzheimer's Disease
Bruyère Health Research Institute. 99
Testing effectiveness (Phase 2)Looking for participantsNCT07457125
What this trial is testing

The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Xuanwu Hospital, Beijing 33
Early research (Phase 1)Study completedNCT02127476
What this trial is testing

Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Kyowa Kirin Co., Ltd. 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT06427668
What this trial is testing

Study of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Spinogenix 24
Next Page